Transaction #5893 · Form 4 · 0002020969-25-000004
RECURSION PHARMACEUTICALS, INC. · Stock award · Stock Option (Right to Buy)
RECURSION PHARMACEUTICALS, INC. · Transacted November 5, 2025 · Filed November 6, 2025
What does this filing report?
An SEC Form 4 filing for RECURSION PHARMACEUTICALS, INC. records a stock award involving Stock Option (Right to Buy) on November 5, 2025. The reported quantity was 169,851. The filing date is November 6, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001601830
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 169,851
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 169,851
- Ownership description
- Not reported
- SEC acceptance time
- Nov 6, 2025, 4:23 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Khan Najat ↗
Chief R&D Commercial Officer · Director
CIK 0002020969
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Class A Common Stock
- Underlying quantity
- 169,851
- Conversion / exercise price
- 4.96
- Exercise date
- Not reported
- Expiration date
- November 5, 2035
Filing footnotes & remarks
- F1
- This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on February 15, 2026, and every three months thereafter.
- F2
- The option vests as to one forty-eighth (1/48th) of the shares subject to the option on December 5, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.